Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-017885

Chief Financial Officer gave up 3,044 shares (to pay taxes)

  • Chief Financial Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foster Jonathan P. Chief Financial Officer 2023-06-16 Option exercise +12,500 23,623 D: show line 1 in the form
Foster Jonathan P. Chief Financial Officer 2023-06-16 Shares withheld for taxes −3,044 $0.57 $1,735 20,579 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Foster Jonathan P. Chief Financial Officer 2023-06-16 Option exercise · Restricted Stock Units −12,500 721,605 D: show line 3 in the form
Loading xslF345X04/rdgdoc.xml…